Pictured (L-R): Howard Lewin, Nusano co-founder & Chief Product Development Officer; Glenn Rosenthal, Nusano...
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
read more
News
Nusano Establishes Strategic Advisory Board to Support Innovation Across Company’s Product Verticals
The Honorable Dr. David J. Shulkin, Corey Johnston and Seema Singh Bhan Appointed as Initial Advisory Board...
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
Pairing of custom-built klystrons and fast-pulse modulators enable production of up 12 radioisotopes in a single run...
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
The following is a copy of a press release issued by Cellectar BiosciencesPartnership Provides Long-Term Supply of...
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapies DURHAM,...
Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals
Agreement provides Ratio access to Nusano-produced radioisotopes for oncology diagnostics and therapeutics Accelerates...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates